Metrikler
Yayın
75
Açık Erişim
12
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1990 - 1993
1990 - 1993Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Kanser Enstitüsü, Klinik Onkoloji Anabilim Dalı, Türkiye
1986 - 1990
1986 - 1990Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1978 - 1984
1978 - 1984Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Tıp Pr., Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2001 - Devam Ediyor
2001 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
Akademi Dışı Deneyim
2001 - Devam Ediyor
2001 - Devam EdiyorPROFESÖR
HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ İÇ HASTALIKLARI ANABİLİM DALI, PROFESÖR
1997 - 2001
1997 - 2001DOÇENT
HACETTEPE ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ, DOÇENT
1993 - 1997
1993 - 1997YARDIMCI DOÇENT
HACETTEPE ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ, YARDIMCI DOÇENT
1990 - 1993
1990 - 1993TIBBİ ONKOLOJİ ARAŞTIRMA GÖREVLİSİ
HACETTEPE ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ, TIBBİ ONKOLOJİ ARAŞTIRMA GÖREVLİSİ
1986 - 1990
1986 - 1990İÇ HASTALIKLARI ARAŞTIRMA GÖREVLİSİ
HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ İÇ HASTALIKLARI ANABİLİM DALI, İÇ HASTALIKLARI ARAŞTIRMA GÖREVLİSİ
1984 - 1986
1984 - 1986PRATİSYEN HEKİM
GÜMÜŞHANE KIRIKLI SAĞLIK OCAĞI, PRATİSYEN HEKİM
Makaleler
Tümü (58)
SCI-E, SSCI, AHCI (56)
SCI-E, SSCI, AHCI, ESCI (58)
ESCI (3)
Scopus (58)
TRDizin (7)
2025
20251. Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study
ŞAHİN T. K., Sahin E. A., Gungor H. N., GÜVEN D. C., BARIŞTA İ., AKIN S.
CANCER MEDICINE
, sa.7, 2025 (SCI-Expanded, Scopus)
2025
20252. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer
BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE
, sa.5, 2025 (SCI-Expanded, Scopus)
2024
20243. Immunohistochemical expression of p53 in adult Burkitt lymphomas
Ozogul E., Sayinalp B., Uner A., Ayhan A. S., Akin S., Barista I., et al.
VIRCHOWS ARCHIV
, 2024 (SCI-Expanded, Scopus)
2024
20244. Fear of cancer recurrence and its predictors in lymphoma patients and their family caregivers: A cross-sectional study
Sahin T. K., Sahin E. A., Gungor H. N., Guven D. C., Barista I., Akin S.
ANNALS OF ONCOLOGY
, 2024 (SCI-Expanded, Scopus)
2024
20245. Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management
AKYILDIZ A., Ismayilov R., Rustamova N., Tokatli M., KOÇ İ., AKIN S., et al.
Annals of Hematology
, cilt.103, sa.3, ss.905-915, 2024 (SCI-Expanded, Scopus)
2024
20246. Bilateral Testicular Plasmacytoma Preceding Multiple Myeloma with Extramedullary Renal Involvement: A Case Report
KAVGACI G., KÖKSAL B., ARIK Z., BARIŞTA İ., AKIN S.
PLASMATOLOGY
, cilt.18, 2024 (ESCI, Scopus)
2023
20237. Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkish oncology group study
Acar R., PAYDAŞ S., Yildirim M., Kiliçarslan E., Sahin U., DOĞAN A., et al.
Journal of Cancer Research and Therapeutics
, cilt.19, sa.8, 2023 (SCI-Expanded, Scopus)
2023
20238. Biochemical Response Evaluation on Lymphomas: Proposing a Scoring System
ERDAT E. C., ARIK Z., BARIŞTA İ.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.33, sa.3, ss.170-178, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
20229. Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review
YILDIRIM H. Ç., AKYILDIZ A., Ismayilov R., Demirok N., BENLİ B. S., Guven D. C., et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
, cilt.15, sa.4, ss.307-310, 2022 (ESCI, Scopus)
2022
202210. A Rare Central Nervous System Involvement Due to CTLA-4 Gene Defect
Rovshanov S., GÖÇMEN R., BARIŞTA İ., ÇAĞDAŞ AYVAZ D. N., ÜNER A., Çilingir V., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.59, sa.3, ss.248-252, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202111. Sarcopenia and anthracycline cardiotoxicity in patients with cancer
BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
202112. Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma
PAYDAŞ S., LAÇİN Ş., Dogan M., BARIŞTA İ., Yildiz B., SEYDAOĞLU G., et al.
LEUKEMIA RESEARCH
, cilt.107, 2021 (SCI-Expanded, Scopus)
2021
202113. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study
Karadurmus N., PAYDAŞ S., Esin E., Surmeli Z. G., Yildiz B., Erturk I., et al.
ARCHIVES OF MEDICAL SCIENCE
, cilt.17, sa.4, ss.920-927, 2021 (SCI-Expanded, Scopus)
2021
202114. IPS-3 Validation in 1012 cases with classical hodgkin lymphoma
PAYDAŞ S., LAÇİN Ş., Dogan M., BARIŞTA İ., Yildiz B., SEYDAOĞLU G., et al.
LEUKEMIA RESEARCH
, cilt.102, 2021 (SCI-Expanded, Scopus)
2021
202115. Central nervous system involvement in patients with acute myeloid leukemia
YAŞAR H. A., ÇINAR O. E., Koylu N. Y., BARIŞTA İ., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.5, ss.2351-2356, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202016. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
Bekoz H., ÖZBALAK M. M., Karadurmus N., PAYDAŞ S., Turker A., TOPTAŞ T., et al.
ANNALS OF HEMATOLOGY
, cilt.99, sa.11, ss.2565-2576, 2020 (SCI-Expanded, Scopus)
2020
202017. Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)
Turkkan G., Alkan A., PAYDAŞ S., TANRIVERDİ Ö., Karakas Y., Karadurmus N., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, cilt.36, sa.4, ss.640-645, 2020 (SCI-Expanded, Scopus)
2020
202018. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study
OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201919. Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)
Curran D., Matthews S., Rowley S. D., Young J. H., Bastidas A., Anagnostopoulos A., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
, cilt.25, sa.12, ss.2474-2481, 2019 (SCI-Expanded, Scopus)
2019
201920. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial
Bastidas A., de la Serna J., El Idrissi M., Oostvogels L., Quittet P., Lopez-Jimenez J., et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
, cilt.322, sa.2, ss.123-133, 2019 (SCI-Expanded, Scopus)
2016
201621. Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75
Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded, Scopus, TRDizin)
2014
201422. AGGRESSIVE FIBROMATOSIS IN CHILDREN: A SINGLE CENTER EXPERIENCE
Varan A., Akyuz C., AYDIN G. B., Yildiz F., Barista I., Yalcin B., et al.
PEDIATRIC BLOOD & CANCER
, cilt.61, 2014 (SCI-Expanded, Scopus)
2013
201323. Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience
KILIÇKAP S., BARIŞTA İ., ÜLGER Ş., ÇELİK İ., SELEK U., YILDIZ F., et al.
BALKAN MEDICAL JOURNAL
, cilt.30, sa.2, ss.178-185, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201224. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
AKYÜREK N., ÜNER A., BENEKLİ M., BARIŞTA İ.
CANCER
, cilt.118, sa.17, ss.4173-4183, 2012 (SCI-Expanded, Scopus)
2012
201225. Long-term complications in Hodgkin's lymphoma survivors
KILIÇKAP S., BARIŞTA İ., Ulger S., ÇELİK İ., SELEK U., Gullu I., et al.
TUMORI
, cilt.98, sa.5, ss.601-606, 2012 (SCI-Expanded, Scopus)
2012
201226. Rapid-Infusion Rituximab in Lymphoma Treatment: 2-Year Experience in a Single Institution
Atay S., BARIŞTA İ., GÜNDOĞDU F., Akgedik K., Arpaci A.
JOURNAL OF ONCOLOGY PRACTICE
, cilt.8, sa.3, ss.141-143, 2012 (SCI-Expanded, ESCI, Scopus)
2011
201127. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'
ÜNER A., AKYÜREK N., Saglam A., Abdullazade S., Uzum N., Onder S., et al.
APMIS
, cilt.119, ss.309-316, 2011 (SCI-Expanded, Scopus)
2010
201028. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis
YILDIRIM F., KARADUMAN A., HÜRMÜZ P., Ozyar E., BARIŞTA İ., Saglam A.
JOURNAL OF CUTANEOUS PATHOLOGY
, cilt.37, sa.5, ss.600-604, 2010 (SCI-Expanded, Scopus)
2010
201029. Fitting the Pieces of the POEMS Syndrome Jigsaw Puzzle-Guillain-Barre Syndrome in a Patient with Refractory Ascites: Case Report
Shorbagi A., ÖNAL İ. K., Onal E. D., KILIÇKAP S., BARIŞTA İ., Kansu T., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.30, sa.1, ss.352-355, 2010 (SCI-Expanded, Scopus)
2009
200930. Oxaliplatin Induced Hemolytic Anemia
Harputluoglu H., Dizdar O., AKSOY S., BARIŞTA İ.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.19, sa.2, ss.127-128, 2009 (SCI-Expanded, Scopus, TRDizin)
2008
200831. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma
KILIÇKAP S., Yavuz B., AKSOY S., Sahiner L., DİNÇER M., HARPUTLUOĞLU H., et al.
MEDICAL ONCOLOGY
, cilt.25, sa.4, ss.437-442, 2008 (SCI-Expanded, Scopus)
2008
200832. Clinicopathologic evaluation of non-Hodgkin lymphoma (NHL): A single centre experience
Kilickap S., Barista I., Turkmen E., Dizdar O., Aksoy S., Turker A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
200833. Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C
DİZDAR Ö., Tapan U., AKSOY S., Harputluoglu H., KILIÇKAP S., BARIŞTA İ.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.80, sa.5, ss.381-385, 2008 (SCI-Expanded, Scopus)
2008
200834. Characteristics of breast cancer patients with central nervous system metastases: A single-center experience
Harputluoglu H., DİZDAR Ö., AKSOY S., KILIÇKAP S., Dede D. S., Ozisik Y., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.5, ss.521-526, 2008 (SCI-Expanded, Scopus)
2008
200835. Prognostic impact of bone turnover markers in multiple myeloma
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2007
200736. Rituximab-induced viral infections in lymphoma patients
Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)
2007
200737. Early and late arrhythmogenic effects of doxorubicin
Kilickap S., Barista I., Akgul E., Aytemir K., Aksoy S., Tekuzman G.
SOUTHERN MEDICAL JOURNAL
, cilt.100, sa.3, ss.262-265, 2007 (SCI-Expanded, Scopus)
2007
200738. Rituximab-related viral infections in lymphoma patients
Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.
LEUKEMIA & LYMPHOMA
, cilt.48, sa.7, ss.1307-1312, 2007 (SCI-Expanded, Scopus)
2007
200739. Macrophage inflammatory protein-1 alpha: A link between innate immunity and familial mediterranean fever?
Dizdar O., Kalyoncu U., Karadag O., Akdogan A., Kiraz S., Ertenli I., et al.
CYTOKINE
, cilt.37, sa.1, ss.92-95, 2007 (SCI-Expanded, Scopus)
2006
200640. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum
Koca E., Duman A. E., Cetiner D., Buyukasik Y., Haznedaroglu I. C., ÜNER A., et al.
NETHERLANDS JOURNAL OF MEDICINE
, cilt.64, sa.11, ss.422-424, 2006 (SCI-Expanded, Scopus)
2006
200641. Reply to "Troponins in prediction of cardiotoxic effects", by D. Cardinale et al.
Kilickap S., Barista I., Aytemir K.
ANNALS OF ONCOLOGY
, cilt.17, sa.1, 2006 (SCI-Expanded, Scopus)
2005
200542. IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation
Abali H., Oyan B., Koc Y., Kars A., Barista I., ÜNER A., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.28, sa.3, ss.264-269, 2005 (SCI-Expanded, Scopus)
2005
200543. Doxorubicin-induced second degree and complete atrioventricular block
Kilickap S., AKGUL E., Aksoy S., Aytemir K., Barista I.
EUROPACE
, cilt.7, sa.3, ss.227-230, 2005 (SCI-Expanded, Scopus)
2004
200444. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease
Yildiz F., Zengin N., Engin W., Gullu E., Barista I., Caglar M., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.60, sa.3, ss.839-846, 2004 (SCI-Expanded, Scopus)
2004
200445. Lung hilar Ga-67 uptake in patients with lymphoma following chemotherapy
Gunay E., Salanci B., Barista I., Caner B.
ANNALS OF NUCLEAR MEDICINE
, cilt.18, sa.5, ss.391-397, 2004 (SCI-Expanded, Scopus)
2004
200446. A patient presenting with spinal cord compression who had two distinct follicular cell type thyroid carcinomas
Koca E., Sokmensuer C., Yildiz B., Engin H., Bozkurt M., Aras T., et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
, cilt.27, sa.6, ss.562-564, 2004 (SCI-Expanded, Scopus)
2004
200447. Comments on "Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma" by M. Binn, A. Ruskone-Fourmestraux, E. Lepage et al. (Ann Oncol 2003; 14 : 1751-1757)
Abali H., Barista I.
ANNALS OF ONCOLOGY
, cilt.15, sa.5, ss.841-842, 2004 (SCI-Expanded, Scopus)
2004
200448. Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)
OYAN ULUÇ B., Tekuzman G., BARIŞTA İ., Ozisik Y., kars A., Turker A., et al.
ANNALS OF ONCOLOGY
, cilt.15, ss.153, 2004 (SCI-Expanded, Scopus)
2004
200449. Thymic malignancy in a breast cancer patient - Is there an association with anti-estrogenic effects of tamoxifen?
Oyan B., Aksoy S., Yavas O., Kars A., Turker A., Barista I.
ACTA ONCOLOGICA
, cilt.43, sa.1, ss.115-116, 2004 (SCI-Expanded, Scopus)
2003
200350. Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer
Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
, cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded, Scopus)
2003
200351. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors
Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.
TUMORI
, cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus)
2002
200252. Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: Results of a single-center study of 32 patients
Ozturk M., Barista I., Altundag M., Turker A., Yalcin S., Celik I., et al.
CHEMOTHERAPY
, cilt.48, sa.5, ss.252-258, 2002 (SCI-Expanded, Scopus)
2000
200053. An unusual case of metastatic rectal carcinoma presenting as thyroid nodule
Koklu S., Barista I., Altundag M., Aksu S., Firat P.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, cilt.95, sa.12, ss.3689, 2000 (SCI-Expanded, Scopus)
2000
200054. Gastric lymphomas in Turkey - Analysis of prognostic factors with special emphasis on flow cytometric DNA content
Aydin Z., Barista I., Canpinar H., Sungur A., Tekuzman G.
CANCER
, cilt.89, sa.1, ss.12-20, 2000 (SCI-Expanded, Scopus)
2000
200055. Intrathecal cytarabine and bone marrow suppression
Barista I.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.18, sa.9, ss.2003, 2000 (SCI-Expanded, Scopus)
2000
200056. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet's disease: a randomised trial
Demiroglu H., Ozcebe O., Barista I., Dundar S., Eldem B.
LANCET
, cilt.355, sa.9204, ss.605-609, 2000 (SCI-Expanded, Scopus)
2000
200057. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., et al.
JOURNAL OF SURGICAL ONCOLOGY
, cilt.73, sa.1, ss.12-16, 2000 (SCI-Expanded, Scopus)
2000
200058. Primary breast lymphomas - A retrospective analysis of twelve cases
Barista I., Baltali E., Tekuzman G., Kars A., Ruacan S., Ozisik Y., et al.
ACTA ONCOLOGICA
, cilt.39, sa.2, ss.135-139, 2000 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2020
20201. Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer
Bas O., Erdemir A., Onur R., Guner G., Guven D. C., Aksu S., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2018
20182. İki olgu nedeniyle Nivolimumaba bağlı akciğer toksisitesi
BABAOĞLU E., SARINÇ ULAŞLI S., KÖKSAL D., ERMAN M., BARIŞTA İ.
Ulusal Akciğer Sağlığı Kongresi, Türkiye, 14 - 18 Mart 2018, (Özet Bildiri)
2017
20173. NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY
Ferhanoglu B., Bekoz H., Karadurmus N., Paydas S., Gulbas Z., Turker A., et al.
22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.84-85, (Özet Bildiri)
2017
20174. Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.
Karadurmus N., Paydas S., Ocal R., Yildiz B., Nayir E., Dogan M., et al.
53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri)
2015
20155. Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation
ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)
2015
20156. Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma
ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)
2015
20157. The retrospective analysis of central nervous system lymphomas: Single-center experience.
Sunar V., Yasar A., Sarici F., Esin E., Diker O., Lacin S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
20158. Autologous/Allogeneic Stem Cell Transplantation following High-dose Sequential Chemotherapy in Patients with Stage III-IV Burkitt and Lymphoblastic Lymphoma : Long term survival data from LLBL2001 protocol
Gungor B., Unsal C., Barista I., Adam M., Koc Y.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)
2012
20129. HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN REFRACTORY/METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS: GATA SINGLE CENTER RESULTS
Karadurmus N., Ataergin A. S., Erdem G., Cakar M., Barista I., Turker T., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.286, (Özet Bildiri)
2012
201210. The comparison of up-front autologous peripheral stem cell transplantation in first remission and long-lasting intensive chemotherapy protocols in highly aggressive non-Hodgkin's lymphomas: Results of a retrospective analysis.
Ozturk M., Ozaydin S., Oyan B., ÖZBALAK M. M., Arpaci F., Paydas S., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2010
201011. BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
Akyurek N., ÜNER A., Benekli M., Barista I.
99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, Kiribati, 20 - 26 Mart 2010, cilt.90, (Özet Bildiri)
2007
200712. Characteristics of breast cancer patients with central nervous system metastases and factors associated with survival after development of central nervous system metastasis
Harputluoglu H., Dizdar O., Aksoy S., Kilickap S., Dede D. S., Ozisik Y., et al.
30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106, (Özet Bildiri)
2006
200613. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma
Kilickap S., Yavuz B., Aksoy S., Sahiner L., Harputluoglu H., Dincer M., et al.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.202, (Özet Bildiri)
2005
200514. Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2004
200415. Increased Troponin-T level is associated with anthracycline-induced diastolic dysfunction of the left ventricle.
Kilickap S., Barista I., Akgul E., Aytemir K., Aksoyek S., Celik I., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
2004
200416. Clinicopathological features and outcome of primary gastric lymphoma: A series of 73 cases
Oyan B., Tekuzman G., Barista I., Kars A., Turker A., Ozisik Y., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
2003
200317. PTEN expression in diffuse large B-cell lymphomas
Onder S., Barista I., Sungur A., Ruacan S., ÜNER A.
17th European and African Division Meeting of the International-Society-of-Haematology, Graz, Avusturya, 7 - 10 Eylül 2003, ss.125-131, (Tam Metin Bildiri)